Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Short-term steroid therapy, sometimes with long-term sequelae].

D van Schaardenburg¹, H R van den Brink, H J Wieringa

¹Jan van Breemen Instituut, Centrum voor Reumatologie en Revalidatie, Dr. Jan van Breemenstraat 2, 1056 AB Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde

|October 5, 2001

Summary

Short-term dexamethasone use can lead to osteonecrosis, a debilitating bone condition. Even brief corticosteroid therapy, like three weeks or less, poses a risk for this serious complication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to 'Effect of a multidisciplinary lifestyle intervention on body composition in people with osteoarthritis: Secondary analysis of the "Plants for Joints" randomized controlled trial' [Osteoarthritis and Cartilage Open 6 (2024) 100524].

Osteoarthritis and cartilage open·2025

Same author

A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the 'Plants for Joints' randomized controlled trials.

Scandinavian journal of rheumatology·2025

Same author

Effect of a multidisciplinary lifestyle intervention on body composition in people with osteoarthritis: Secondary analysis of the "Plants for Joints" randomized controlled trial.

Osteoarthritis and cartilage open·2024

Same author

Cost-utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations.

Scandinavian journal of rheumatology·2024

Same author

[Temporomandibular dysfunction and bruxism in patients with early rheumatoid arthritis and at-risk patients: a cross-sectional study].

Nederlands tijdschrift voor tandheelkunde·2024

Same author

Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning.

Scandinavian journal of rheumatology·2023

Area of Science:

Endocrinology
Orthopedics
Pharmacology

Background:

Corticosteroids, such as dexamethasone, are widely used for their anti-inflammatory and immunosuppressive properties.
Osteonecrosis, or bone death, is a known but often under-recognized complication associated with corticosteroid therapy.
The relationship between corticosteroid dosage, duration of treatment, and the risk of osteonecrosis is a significant clinical concern.

Observation:

Two patients developed osteonecrosis (bone death) after short-term intravenous dexamethasone treatment.
A 35-year-old male experienced bilateral femoral and humeral head osteonecrosis after 3 weeks of dexamethasone for subarachnoid hemorrhage.
A 45-year-old female developed osteonecrosis in the femoral condyles, talus, and calcaneus after 1 week of dexamethasone for reflex dystrophy.

Related Experiment Videos

Findings:

Osteonecrosis occurred 1-2 years post-treatment, affecting multiple joints in both patients.
The male patient had hyperlipidemia as an additional risk factor.
The findings suggest that even short-term corticosteroid use (≤3 weeks) can precipitate osteonecrosis.

Implications:

Corticosteroid-induced osteonecrosis can be a long-term, debilitating complication requiring extensive medical intervention.
Clinicians should be vigilant about the risk of osteonecrosis, even with short courses of corticosteroids.
Further research into risk stratification and preventative strategies for corticosteroid-induced osteonecrosis is warranted.